MDR1 genetic polymorphism does not modify either cell permissiveness to HIV-1 or disease progression before treatment

J Infect Dis. 2004 Feb 15;189(4):583-6. doi: 10.1086/380134. Epub 2004 Jan 29.

Abstract

Nonphysiological overexpression of the ABC transporter P-glycoprotein (P-gp), which is encoded by MDR1, has been associated with reduced susceptibility to human immunodeficiency virus (HIV) type 1 infection in vitro. We analyzed (1) the expression and genotype of MDR1 and their relationship to HIV-1 permissiveness of CD4+ T cells from 128 healthy blood donors and (2) the role that alleles of MDR1 exons 21 and 26 play in modifying disease progression in 411 HIV-1-infected individuals. Differences in physiological levels of MDR1 expression did not modify HIV-1 infection in vitro, nor did MDR1 alleles and haplotypes significantly influence either permissiveness to infection in vitro or disease progression in vivo before the initiation of treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acquired Immunodeficiency Syndrome / genetics*
  • Acquired Immunodeficiency Syndrome / physiopathology
  • Base Sequence
  • CD4-Positive T-Lymphocytes / immunology
  • Cohort Studies
  • DNA Primers
  • Disease Progression
  • Genes, MDR / genetics*
  • Genetic Variation
  • Genotype
  • HIV Infections / genetics*
  • HIV Infections / physiopathology
  • HIV-1
  • Humans
  • Polymorphism, Genetic*

Substances

  • DNA Primers